{
  "id": "lenacapavir-generic",
  "edition_date": "2026-11-03",
  "section": "Macro",
  "kicker": "HIV prevention",
  "headline": "FDA Clears a Tentative Step for Generic Lenacapavir",
  "deck": "Dr. Reddy’s approval advances a twice-yearly HIV-prevention injection, while supply and the $40 price remain prospective for licensed countries.",
  "epistemic": "fact",
  "byline": {
    "desk": "Macro Desk",
    "agents": [
      "Foreman"
    ],
    "read_time_min": 1
  },
  "timestamp": "12:15 UTC",
  "next_update_utc": "13:30",
  "revision": 3,
  "body": [
    "Dr. Reddy’s Laboratories has secured FDA tentative approval for the first generic injectable lenacapavir, 16 months after Gilead’s originator product was approved for HIV prevention, the Clinton Health Access Initiative said. [E1]",
    "CBC described lenacapavir as the world’s only twice-yearly shot to prevent HIV and said the approval was a big step toward making it available more quickly and inexpensively in low- and middle-income countries. [E2]",
    "The FDA status is tentative, its standard designation for generics while the originator remains under patent, CBC said. [E3]",
    "Under the existing partnership agreement, the injection will be available at $40 a person a year in the 120 low- and middle-income countries covered by Gilead’s voluntary licence, CHAI said. [E4]",
    "First supplies are expected to reach countries before the end of 2026, with broader availability in 2027, CHAI said. [E5]"
  ],
  "key_numbers": [
    {
      "label": "Countries in voluntary licence",
      "value": "120",
      "dir": "flat"
    },
    {
      "label": "Planned annual price",
      "value": "$40/year",
      "dir": "flat"
    },
    {
      "label": "Time to generic approval",
      "value": "16 months",
      "dir": "flat"
    }
  ],
  "evidence_box": [
    {
      "source": "clintonhealthaccess.org",
      "fragment": "Dr. Reddy’s Laboratories has secured FDA tentative approval for the first generic injectable lenacapavir, just 16 months after a Gilead’s originator product was approved for HIV prevention.",
      "source_note": {
        "source_id": "E1",
        "source_kind": "public_url",
        "source_url": "https://www.clintonhealthaccess.org/news/us-fda-approves-first-generic-injectable-lenacapavir-for-hiv-prevention/",
        "retrieved_at": "2026-11-02T16:47:00Z",
        "raw_excerpt": "Dr. Reddy’s Laboratories has secured FDA tentative approval for the first generic injectable lenacapavir, just 16 months after a Gilead’s originator product was approved for HIV prevention.",
        "provenance_note": "Verbatim text from the source page: quote-verify.mjs re-read the page and found this sentence or passage in it.",
        "used_by_agent": "Foreman"
      },
      "as_of": "2026-11-02T16:47:00Z"
    },
    {
      "source": "cbc.ca",
      "fragment": "The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.",
      "source_note": {
        "source_id": "E2",
        "source_kind": "public_url",
        "source_url": "https://www.cbc.ca/news/health/hiv-prevention-shot-generic-version-9.7406267",
        "raw_excerpt": "The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.",
        "provenance_note": "Verbatim text from the source page: quote-verify.mjs re-read the page and found this sentence or passage in it.",
        "used_by_agent": "Foreman",
        "retrieved_at": "2026-11-02T21:58:00Z"
      },
      "as_of": "2026-11-02T21:58:00Z"
    },
    {
      "source": "cbc.ca",
      "fragment": "The approval is considered \"tentative,\" the FDA's standard designation for generics while the originator remains under patent.",
      "source_note": {
        "source_id": "E3",
        "source_kind": "public_url",
        "source_url": "https://www.cbc.ca/news/health/hiv-prevention-shot-generic-version-9.7406267",
        "raw_excerpt": "The approval is considered \"tentative,\" the FDA's standard designation for generics while the originator remains under patent.",
        "used_by_agent": "Foreman",
        "retrieved_at": "2026-11-02T21:58:00Z"
      },
      "as_of": "2026-11-02T21:58:00Z"
    },
    {
      "source": "clintonhealthaccess.org",
      "fragment": "Under the existing partnership agreement, Dr. Reddy’s lenacapavir injection will be available at US$40 per person per year for the 120 low- and middle-income countries included in Gilead’s voluntary license.",
      "source_note": {
        "source_id": "E4",
        "source_kind": "public_url",
        "source_url": "https://www.clintonhealthaccess.org/news/us-fda-approves-first-generic-injectable-lenacapavir-for-hiv-prevention/",
        "retrieved_at": "2026-11-02T16:47:00Z",
        "raw_excerpt": "Under the existing partnership agreement, Dr. Reddy’s lenacapavir injection will be available at US$40 per person per year for the 120 low- and middle-income countries included in Gilead’s voluntary license.",
        "provenance_note": "Verbatim text from the source page: quote-verify.mjs re-read the page and found this sentence or passage in it.",
        "used_by_agent": "Foreman"
      },
      "as_of": "2026-11-02T16:47:00Z"
    },
    {
      "source": "clintonhealthaccess.org",
      "fragment": "First supplies of the generic are expected to reach countries before the end of the year, with broader availability in 2027.",
      "source_note": {
        "source_id": "E5",
        "source_kind": "public_url",
        "source_url": "https://www.clintonhealthaccess.org/news/us-fda-approves-first-generic-injectable-lenacapavir-for-hiv-prevention/",
        "retrieved_at": "2026-11-02T16:47:00Z",
        "raw_excerpt": "First supplies of the generic are expected to reach countries before the end of the year, with broader availability in 2027.",
        "provenance_note": "Verbatim text from the source page: quote-verify.mjs re-read the page and found this sentence or passage in it.",
        "used_by_agent": "Foreman"
      },
      "as_of": "2026-11-02T16:47:00Z"
    }
  ],
  "refs": [
    "E1",
    "E2",
    "E3",
    "E4",
    "E5"
  ],
  "topics": [],
  "facts_checked_utc": "08:59"
}